[Corrigendum] miRNA‑183‑5p.1 promotes the migration and invasion of gastric cancer AGS cells by targeting TPM1

Lin,Jun; Shen,Juan; Yue,Hao; Cao,Zhongwei

doi:10.3892/or.2020.7902

February-2021 Volume 45 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

February-2021 Volume 45 Issue 2

Full Size Image

Correction Open Access

[Corrigendum] miRNA‑183‑5p.1 promotes the migration and invasion of gastric cancer AGS cells by targeting TPM1

Authors:
- Jun Lin
- Juan Shen
- Hao Yue
- Zhongwei Cao
View Affiliations / Copyright

Affiliations: Department of Pathology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200080, P.R. China, Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200080, P.R. China

Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Pages: 789-790
|
Published online on: December 16, 2020

https://doi.org/10.3892/or.2020.7902
Expand metrics +

Article

Oncol Rep 42: [Related article:] 2371-2381, 2019; DOI: 10.3892/or.2019.7354

Following the publication of the above article, an interested reader drew to the authors’ attention that an apparent duplication of data panels had occurred in Fig. 4; essentially, the pre-NC/GES-1 and pre-NC/MKN-7 panels in Fig. 4A and C, respectively, appeared very similar to each other, with the exception of different values reported for the gated percentages. The authors consulted their original data and were able to determine that the error arose inadvertently during the process of compiling the figure.

Figure 4.

miR-183-5p.1 regulates the apoptosis of GC cells as detected by flow cytometry. miR-183-5p.1 inhibitors increased the apoptosis of (A and B) GES-1, (C and D) MKN-7, (E and F) AGS and (G and H) HGC-27 cells, while miR-183-5p.1 mimics significantly inhibited the apoptosis of (A and B) GES-1, (C and D) MKN-7, (E and F) AGS and (G and H) HGC-27 cells. Results are presented as the mean ± standard error of the mean (n=3). *P<0.05, **P<0.01. GC, gastric cancer; miR, microRNA.

The revised version of Fig. 4, featuring the corrected data for the pre-NC/MKN-7 panel in Fig. 4C, is shown on the next page. The authors have confirmed that the errors associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum. Furthermore, they apologize to the readership of the Journal for any inconvenience caused.